Bayer reports positive early data for Parkinson’s cell therapy

The therapy, developed by Bayer’s Bluerock Therapeutics subsidiary, appeared safe and well-tolerated in a 12-person clinical trial.

Published Aug. 28, 2023

Bayer reports positive early data for Parkinson’s cell therapy | BioPharma Dive: Bayer reports positive early data for Parkinson’s cell therapy
Facebook
Twitter
LinkedIn